CD163 and systemic sclerosis: Intriguingly, a recent study revealed that a considerable number of M2 Mo (CD204+CD163+CD206+) co-expressed M1 markers (CD80 and CD86) in the PBMCs of SSc patients, and this subset of cells constituted a significant feature that characterized SSc (23).